Quantcast

Latest Ocular hypertension Stories

2014-06-30 08:31:35

TEL AVIV, Israel, June 30, 2014 /PRNewswire/ -- BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT)(OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D(R), the company's controlled-release latanoprost insert for the treatment of glaucoma. This randomized,...

2014-06-24 08:32:41

MENLO PARK, Calif., June 24, 2014 /PRNewswire/ -- ForSight VISION5 is pleased to announce that Charles Semba, MD has joined the company as Chief Medical Officer from Shire Pharmaceuticals where he served as Vice President, Clinical Medicine (Ophthalmology). ForSight VISION5 is developing non-invasive drug delivery products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy....

2014-05-14 12:22:24

TEL-AVIV, Israel, May 14, 2014 /PRNewswire/ -- BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT)(OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has been informed that a patent number 8,722,739 covering the proprietary formulation of Latanoprost, the medication contained in its controlled release insert for the...

2014-05-13 08:30:57

DIEPENBEEK, Belgium, May 13, 2014 /PRNewswire/ -- Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma. Based on Amakem's 'Localized Drug Action' platform, AMA0076 is a highly potent locally-acting Rho Kinase (ROCK) inhibitor that has been designed to reduce intraocular pressure (IOP) by acting...

2014-02-07 23:00:40

MarketResearchReports.Biz announces addition of new report “Global Ocular Hypertension Clinical Trials And Research Reports 2014” to its database. Visit: http://www.marketresearchreports.biz/analysis/186897. Albany, NY (PRWEB) February 08, 2014 Ocular Hypertension Global Clinical Trials Review, H1, 2014 "Ocular Hypertension Global Clinical Trials Review, H1, 2014" provides data on the Ocular Hypertension clinical trial scenario. This report provides elemental information...

2014-02-04 12:28:40

DIEPENBEEK, Belgium, February 4, 2014 /PRNewswire/ -- Amakem Therapeutics, a clinical stage ophthalmology company, today announced that it will participate in the Glaucoma 360 New Horizons Forum being held on Friday, February 7, 2014 at The Palace Hotel, in San Francisco. This meeting, presented by Glaucoma Research Foundation, brings together key clinical, industry, financial and regulatory leaders in a unique exchange on research innovation and advances in glaucoma...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related